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INTRODUCTION
Patent reform has become, perhaps improbably, one of the most
contentious issues facing Congress and the courts over the past six
years. The fights range across a number of major issues, which not
only separate patent owners from patent defendants and those who
believe in innovation incentives from those who believe in market
competition, but also divide patent owners themselves along both industry and technology lines. Advocates on both sides paint seemingly
irreconcilable pictures of the patent system, either as a stable system
with clearly defined legal rights essential to innovation or as a system
rampant with litigation abuse by “patent trolls” who use the legal sys1
tem to divert money from innovative companies.
Far too much of this debate is based on anecdote and assumption,
not real data. Pharmaceutical patent owners assume that most of the
world works the way their industry does; so, too, do information technology (IT) companies. Patent trolls are variously portrayed as responsible for the majority of all patent lawsuits, for no more than two
2
percent, or as mythical creatures that do not actually exist.
1

On these two views of the world, see DAN L. BURK & MARK
TENT CRISIS AND HOW THE COURTS CAN SOLVE IT 3-6 (2009).
2

A. LEMLEY, THE PA-

See, e.g., Patent Trolls: Fact or Fiction: Hearing Before the Subcomm. on Courts, the
Internet, and Intell. Prop. of the H. Comm. on the Judiciary, 109th Cong. 14-18 (2006)
(statement of Dean Kamen, President, Deka Research & Development Corporation)
[hereinafter Kamen Testimony], available at http://frwebgate.access.gpo.gov/cgibin/
getdoc.cgi?dbname=109_house_hearings&docid=f:28201.pdf (questioning whether
patent trolls even exist); Jennifer Kahaulelio Gregory, The Troll Next Door, 6 J. MARSHALL REV. INTELL. PROP. L. 292, 305-09 (2007) (arguing that the term “patent troll”
obscures real problems in the patent system); Mark A. Lemley & Carl Shapiro, Patent
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The opening of the Stanford IP Litigation Clearinghouse in De3
cember 2008 allows us to collect data that give a unique perspective
on many of these debates. Using this data, we identify the patents litigated most frequently between 2000 and 2007 and compare those patents to a control set of patents that have been litigated only once in
that period. The results are startling. The most-litigated patents are
far more likely to be software and telecommunications patents, not
mechanical or other types of patents. They are significantly different
from once-litigated patents in ways that signal their value up front.
And they are disproportionately owned by nonpracticing entities (i.e.,
“trolls”). The results do not answer all of the policy questions; we offer only one important piece of a larger mosaic. But our findings have
significant implications for debates over patent reform, since we show
4
both that the most-litigated patents are the most valuable ones and
Holdup and Royalty Stacking, 85 TEX. L. REV. 1991, 2009 (2007) (asserting that nonpracticing entities account for thirty to forty percent of suits in the computer and electronics industries); Marc Morgan, Stop Looking Under the Bridge for Imaginary Creatures: A Comment Examining Who Really Deserves the Title Patent Troll, 17 FED. CIR. B.J. 165, 166 (2007)
(“In reality only two percent of all patent litigation is linked to so-called trolling.” (footnote omitted)).
3
Press Release, Stanford Law Sch., Stanford Law School Launches Intellectual Property Litigation Clearinghouse (Dec. 8, 2008), available at http://www.law.stanford.edu/
program/centers/iplc/#press_releases. The website of the Stanford IP Litigation
Clearinghouse (IPLC) is located at http://lexmachina.stanford.edu.
4
When we speak of value, we refer to private value, or value to the owner. We also
refer only to the fact of value and not to any quantitative measure of value. We defend
the litigation-value connection extensively in our prior work. See John R. Allison et al.,
Valuable Patents, 92 GEO. L.J. 435, 440-43 (2004) (explaining the intuitive litigationvalue connection and its strong empirical support); see also John R. Allison & Thomas
W. Sager, Commentary, Valuable Patents Redux: On the Enduring Merit of Using Patent
Characteristics to Identify Valuable Patents, 85 TEX. L. REV. 1769, 1794 (2007) (defending
the value-litigation connection). The economics literature supports this connection as
well. See, e.g., Dietmar Harhoff et al., Citations, Family Size, Opposition and the Value of
Patent Rights, 32 RES. POL’Y 1343, 1345 (2003) (finding that “patents which are upheld
against opposition . . . are particularly valuable”); Jean O. Lanjouw & Mark Schankerman, Characteristics of Patent Litigation: A Window on Competition, 32 RAND J. ECON. 129,
140 (2001) [hereinafter Lanjouw & Schankerman, Characteristics] (finding that litigation correlates with patent value and that “the number of claims is another
. . . indicator of the ‘bits of information’ contained in a patent, and therefore its value”); Stuart J.H. Graham et al., Post-Issue Patent “Quality Control”: A Comparative Study of
U.S. Patent Re-examinations and European Patent Oppositions 6-22 (Nat’l Bureau of Econ.
Research, Working Paper No. 8807, 2002) (comparing USPTO and EPO opposition
mechanisms and finding that the most valuable patents were challenged in both systems); Dietmar Harhoff & Markus Reitzig, Determinants of Opposition Against EPO Patent
Grants—The Case of Biotechnology and Pharmaceuticals 4 (Ctr. for Econ. Policy Research,
Discussion Paper No. 3645, 2002) (confirming that “patents with above-average values
are more likely to be attacked”); Jean O. Lanjouw & Mark Schankerman, Enforcing Intellectual Property Rights 5 (Nat’l Bureau of Econ. Research, Working Paper No. 8656,
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that they are most commonly in the hands of companies other than
the ones building new products.
In Part I we describe our study. In Part II we report our results.
Part III discusses the implications of our findings.
I. STUDY DESIGN
5

Only about 1.5% of all patents are ever litigated in court. The
6
majority of patents are worth no more than a few thousand dollars;
litigated patents are almost by definition extreme outliers, since the
parties are willing to spend millions of dollars per side in legal fees in
7
order to litigate them. In prior work, two of the authors demonstrated that litigated patents have significantly different characteristics
8
than other patents. They include more claims, cite more prior art,
2001) (“[M]ore valuable patents . . . are much more likely to be involved in suits.”); cf.
Jean O. Lanjouw & Josh Lerner, The Enforcement of Intellectual Property Rights: A Survey of
the Empirical Literature, 49/50 ANNALES D’ECONOMIE ET DE STATISTIQUE 223 (1998)
(surveying the literature on the issue). This Article both strengthens that conclusion
and demonstrates for the first time a strong relationship between the number of times
a patent is enforced and the determinants of value. It also allows us to refute a hypothesis that we addressed but could not resolve in our prior work: that litigated patents
are valuable, but not the most valuable patents. Litigation, on this account, is evidence
of weakness in a patent. Perhaps competitors quietly take licenses to the truly valuable
patents, and the ones they fight about are akin to an “upper-middle class” of potentially valuable but less-than-perfect patents.
5
Mark A. Lemley, Rational Ignorance at the Patent Office, 95 NW. U. L. REV. 1495,
1507 (2001).
6
See, e.g., Jonathan A. Barney, A Study of Patent Mortality Rates: Using Statistical Survival Analysis to Rate and Value Patent Assets, 30 AIPLA Q.J. 317, 329 (2002) (“A relatively
large number of patents appear to be worth little or nothing while a relatively small
number appear to be worth a great deal.”); Jean O. Lanjouw et al., How to Count Patents
and Value Intellectual Property: The Uses of Patent Renewal and Application Data, 46 J. INDUS. ECON. 405, 412 & n.3 (1998) (noting a variety of studies finding “that most patents are of very little value”); Kimberly A. Moore, Worthless Patents, 20 BERKELEY TECH.
L.J. 1521, 1526 (2005) (documenting the failure of most patentees to pay maintenance
fees costing only a few thousand dollars); Thomas Ewing, Book Review, 43 SANTA CLARA L. REV. 631, 633 (2003) (“Some of the authors simply recount patent procurement
and litigation statistics ad nauseum and do not seem to understand that some patents
really do have no value whatsoever since no one would ever practice the disclosed
technology, as claimed.”). Maintenance fees are due in increasing amounts at 3.5
years, 7.5 years, and 11.5 years after the patent issues. 35 U.S.C. § 41(b) (2006). The
fees are $830 at 3.5 years, $1,900 at 7.5 years, and $2,910 at 11.5 years. Id. Those fees
are halved for small entities. Id. § 41(h)(1).
7
See AM. INTELL. PROP. LAW ASS’N, REPORT OF THE ECONOMIC SURVEY, at I-91
(2007) (reporting that the median cost of high-stakes patent lawsuits is five million dollars per side in legal fees through trial).
8
Allison et al., supra note 4; see also Allison & Sager, supra note 4, at 1794 (defending the statistical power of the results in the earlier study).
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are cited more often by later patents, file more continuation applica9
tions, and come from larger “families” of patents. They are also concentrated in certain industries. For example, semiconductor patents
are particularly unlikely to be litigated because the industry is concen10
trated and cross-licenses are common. Many of these characteristics
are within the control of the patent applicant, and most are known by
the time the patent issues. Allison et al. suggest that these characteris11
tics are evidence of the private value of patents.
That prior work depended significantly on a randomly selected
sample of cases actually litigated. The development of the Stanford IP
Litigation Clearinghouse in December 2008 opened up a second alternative. The Clearinghouse collects every patent-infringement lawsuit filed since January 1, 2000, in searchable format, and links those
12
suits to the patents in suit. Using that database, we identified every
patent that has been litigated eight or more times between 2000 and
13
2007 (including cases still pending). We identified 106 such patents.
For purposes of our study, we also identified a randomly selected control set of 106 patents that have been litigated only once during this
time period. This allows us to extend the work that Allison et al. did in
2004, comparing the “ordinary” litigated patents (already outliers, as we
have seen) to the most-litigated patents. If Allison et al. are correct, we
would expect those most-litigated patents to exhibit even more evidence of private value, and perhaps even more of an industry skew.
To test these hypotheses, we collected a variety of data about both
14
the patents and the patent lawsuits. For each litigated patent, we col9

Allison et al., supra note 4, at 438.
Id. at 468-69.
11
Id. at 460.
12
Due to increased availability of electronic filings in federal court, the ability to
identify patents in suit has improved markedly, particularly since 2003. Moreover, electronic access varies by district, potentially making this patent data set underinclusive for
certain districts despite manual collection of cases from those districts. Nevertheless, the
patents identified represent the best, most representative data set available.
13
For purposes of this analysis, we include declaratory-judgment actions as well as
actions filed by the patent owner. Until 2007, the rules for declaratory judgment required a clear threat of suit by the patent owner. See Teva Pharm. USA, Inc. v. Pfizer,
Inc., 395 F.3d 1324, 1333 (Fed. Cir. 2005) (requiring reasonable apprehension of imminent suit), abrogated by MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007)
(permitting a declaratory judgment action so long as there is an actual controversy between the parties). We count only separate lawsuits; many patent lawsuits are filed
against multiple defendants in a single proceeding.
14
We do not address the outcomes of those lawsuits in this Article; that is the subject of a companion piece by the authors, tentatively entitled Patent Quality and Risk
Aversion Among Repeat Patent Litigants.
10
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lected information about small-entity status (i.e., whether the patent
owner at issue is an individual, university, or small business, as opposed
to a large business); whether the patent is assigned before litigation; the
number of continuation applications filed leading to issuance of the patent; the raw and adjusted number of “forward citations” (citations to
the patent by later patents); the number of “prior art references” the
patent makes to U.S. patents, foreign patents, and nonpatent prior art;
and the number of claims in each patent.
We also categorized each patent into both an industry and a technology in order to ascertain whether significant differences existed in the
15
technology and industry areas. We did not use the Patent and Trademark Office (PTO) classification system because our prior work has
16
found that it is badly flawed. Instead, we did our own categorization. In
our description of technology and industry areas for inventions that we
actually encountered in our data sets, we attempted to define the areas in
a comprehensive way, and our definitions are thus broad enough to in17
clude specific inventions not actually found in our data sets.
A. Technology Areas
(1) Software: An invention in which data processing is a sufficiently critical element that at least one claim element in the patent
consists of data processing—the actual manipulation of data—
15

We did not attempt to create a comprehensive typology of such areas, but for obvious reasons only identified and defined those technology and industry areas we actually
encountered in the population of the 106 most-asserted patents and the sample of 106
once-litigated patents. Although the size of our data sets is sufficient for sound statistical
analysis, the relatively small numbers of observations necessarily results in our having encountered fewer technology and industry areas than we would have encountered in a
much larger patent data set. The technology categories are not necessarily mutually exclusive because modern inventions so often involve multiple technologies.
Our industry categories are also not all mutually exclusive, reflecting the reality of
modern industry crossovers. For example, a software-implemented telecommunications process or product rightly belongs in both a computer and a communications
industry category. There are, however, fewer inventions belonging in more than one
industry category than there are inventions belonging in more than one technology area
because mixes of technologies in inventions are more common than industry crossovers.
16
John R. Allison & Mark A. Lemley, Who’s Patenting What? An Empirical Exploration of Patent Prosecution, 53 VAND. L. REV. 2099, 2114 (2000).
17
Although we report descriptive statistics and bivariate comparisons for all of our
technology and industry areas, we defined a few technology and industry areas encountered in the data set that we ultimately did not subject to statistical testing because
the number of observations for such areas was so small as to render statistical analysis
meaningless. We did this to create definitions of categories that could also be used in
data sets other than the ones we used in this study.
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regardless of whether the code carrying out that data processing is on
a magnetic storage medium or embedded in a chip. The latter is of18
ten called “firmware.” This category includes the two software patent
subsets described below.
(2) Pure software:
An invention consisting only of data
processing; all claim elements in the patent consist of data processing.
However, we include in this definition a patent on data processing in
which there is a trivial nondata processing element such as a generic
input, output, or storage element clearly not intended to represent
any novel technical advance. This category is a subset of software.
(3) Software business method: Also a subset of software patent,
this category includes software patents that cover methods for conducting business transactions. Business-method patents are notoriously difficult to define, with possible definitions varying greatly in scope.
For this study, we used a narrow definition limited to those patents the
claims of which obviously covered only such things as automated generation of customer proposals, advertising, and the use of online catalogs.
(4) Mechanical: A process, machine, or product that consists solely of the use of mechanical parts, sometimes combined with heat, hydraulics, pneumatics, or other power sources; or an invention in
which the above is a critical part. Some inventions classified as mechanical will also be in one or more other classifications, such as electronics. While many different types of inventions fit into this category,
it is not a catchall “other” category.
(5) Electronics: A process, machine, or product in which the invention or a critical part thereof makes use of traditional electronic
circuitry or involves electric-energy storage. An invention in this classification may also be included in other classifications, such as chemistry, mechanics, or optics.
(6) Optics (other than imaging): A process, machine, or product
in which the invention or a critical part thereof employs light waves.
Optics technology will sometimes also be classified in one or more
other areas, such as electronics or chemistry.
(7) Imaging: A process, machine, or product in which the invention or a critical part thereof involves the creation or processing of
images for various purposes. The imaging may be analog or digital.

18

The difficulty in defining a software patent, and the detailed reasoning that
supports our definition, can be found in Arti K. Rai, John R. Allison & Bhaven N. Sampat, University Software Ownership and Litigation: A First Examination, 87 N.C. L. REV. 101,
111-15 (2009).
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The majority of imaging patents have medical uses, but some serve
other purposes such as security or meteorology.
(8) Biotechnology: A process involving advanced genetic techniques intended to construct new microbial, plant, or animal strains; a
product created from such a process; or the way such a process or
product is used in biotechnology research. Although there are a
number of different genetic-engineering techniques, for several reasons we decided not to disaggregate these techniques into separate
technology areas.
(9) Chemistry: A process consisting of chemical reactions, a
product resulting from such a process, an invention of which a chemical process or product is a critical part, or an invention consisting of a
purportedly novel use of chemical substances. Closely related inventions such as those on novel metal alloys and nonmetallic amalgams are
also included. An invention in the field of chemistry may be included
in one or more other classifications, such as electronics or optics.
B. Industry Areas
(1) Computer: This industry encompasses both software and
computer-hardware inventions, including not only hardware products
but also machines and processes for making computer hardware. As
discussed below, some but not all inventions in the semiconductor industry are also included in the computer industry category.
(2) Semiconductor: The semiconductor industry category includes inventions of any kind intended to advance the state of the art
in researching, designing, or fabricating semiconductor chips. Despite the fact that many semiconductor devices are intended to be
computer components, not all are so intended, and we thus do not
automatically include semiconductor patents in the computer industry category. There are situations in which a patent appropriately belongs in both the computer and semiconductor industry categories,
such as a patent on a software or computer-hardware invention specifically for use in semiconductor device fabrication, but this is not an
automatic industry crossover.
(3) Electronics: This is a somewhat narrower version of the electronics technology category. This industry category includes many patents that involve the use of electronics technology, but inventions of
which electronics technology forms a part are not always legitimately
viewed as being within the electronics industry. An example might be
an electro-mechanical process (covered by both the mechanical and
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electronics technology areas) for creating a packaging system for inte19
grated circuits and printed circuit boards.
Although reasonable
minds could differ, it seems most logical to include such an invention
in the computer and semiconductor industries for which the packaging is intended, not in the electrical industry.
(4) Medical: This industry category includes inventions of any
kind used for research on, or for the diagnosis or treatment of, diseases or other abnormal conditions in humans or animals. Patents on
processes and products for pharmaceutical purposes are not included
in the medical industry category.
(5) Pharmaceutical: The pharmaceutical industry category includes patents on drugs for treating diseases or other abnormal conditions in humans or animals, as well as processes for producing or using such drugs.
(6) Biotechnology: In this instance, we concluded that the biotechnology technology area, which we define broadly, should also be an
industry category.
(7) Chemical: The chemical industry category includes inventions
of all kinds that deal primarily with the making, transportation, and
use of chemical substances, except for pharmaceutical drugs. It is both
narrower and broader than the chemistry technology area. It is narrower in the sense that it does not include patents on inventions using
chemical techniques to produce nonchemical products that more logically belong in another industry. For example, a patent including an
element covering the use of chemical techniques in semiconductor
fabrication would not be included in the chemical industry category.
The industry category is broader than the chemistry technology category, as it includes inventions not employing chemistry techniques but
that nevertheless are intended for use by chemical companies, such as
a mechanical invention relating to the handling of chemicals.
(8) Communications: The communications industry category includes patents on inventions of all kinds intended to advance the state
of the art in communications.
(9) Transportation: This category includes patents on any type of
invention related to vehicles of any type, or to the provision of transportation services.
(10) Energy and utility services: This category includes patents on
inventions of any kind associated with power generation, transporta19

U.S. Patent No. 5,551,216 (filed July 20, 1995) (issued Sept. 3, 1996).
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tion, or consumption. Also included are inventions related to the delivery of public utility services.
(11) Financial: This category includes processes and products associated with providing financial services of various kinds. Such patents usually employ software and, if so, are also included in the computer industry category.
(12) Consumer goods and services: This category includes patents
on products and services of all kinds intended for personal consumer
purposes. Also included are patents on methods for marketing, buying, or delivering personal consumer goods or services, which often
will be software implemented and thus will also fall within the computer
industry category.
(13) Construction: The construction industry category includes
inventions of all kinds related to the erection or maintenance of structures, or to excavation.
C. Entity Status
Finally, we investigated the nature of the patent plaintiff. Follow20
ing Lemley and Myhrvold, we categorized each patent owner into
one of the twelve different “entity status” categories listed in Table 1.
Table 1: Entity-Status Classes
Entity Class

20

Description

1

Acquired patents

2

University heritage or tie

3

Failed startup

4

Corporate heritage

5

Individual-inventor-started company

6

University/Government/NGO

7

Startup, pre-product

8

Product company

9

Individual

10

Undetermined

11

Industry consortium

12

IP subsidiary of product company

Mark Lemley and Nathan Myhrvold are currently working on an article, tentatively entitled The Complex Ecology of Patent Plaintiffs, employing this method.
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Of the twelve entity classes, only one (Class 8) involves enforcement by a patent owner that actually makes products. The remainder
21
are different types of “nonpracticing entities,” sometimes called “patent trolls” for the prototypical practice of hiding under a bridge they
did not build and demanding a toll from surprised passersby. Rather
than take a position on what, if any, nonpracticing entities should be
considered “trolls,” we classify each patent owner and let the reader
decide. We do, however, report the results for practicing versus nonpracticing entities (i.e., Class 8 versus other classes) as well as the results for each class.
D. Statistical Analysis
We tested each of the results reported here for statistical significance. We report the results in the tables in most cases. But, unless otherwise noted, the reader should assume that we report only results with a
22
confidence level greater than 99% (i.e., a p-value of less than 0.01).
In addition to descriptive statistics and bivariate comparisons of
23
individual variables between the two data sets, we also checked our
results using logistic regression to determine which differences between the two data sets remained significant after accounting for interactions (correlations) among the variables within each set. Logistic
regression is one form of multiple regression, which is used when
there are multiple predictor (or explanatory) variables and only one
dependent variable (here, either a singly or multiply litigated patent).
We conducted two logistic regressions, one including the key patent characteristics and technology areas, the other including those
same patent characteristics and industry areas.
The patent characteristics included in each regression, some of
which are obviously categorical variables and some of which are obviously continuous variables, were as follows: (1) whether ownership
of the patent had been assigned after issuance and before the first litigation of that patent; (2) whether the patent was initially issued to a
21

After a diligent search, we could not identify the entity status of a few patent
owners. We have classified those entities as 10 (Undetermined) and have excluded
them from our entity-status analyses.
22
In social science research, a confidence level of 95% (p-value of 0.05) is typically
treated as sufficient to show statistical significance. Thus, a confidence level of 99%
(p-value of 0.01) shows a far greater degree of confidence that the differences are not
due to random chance.
23
We used accepted statistical techniques to adjust many of the variables to normalize skewed distributions before making bivariate statistical comparisons.
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small or large entity; (3) the number of U.S. nonprovisional applications leading to the particular patent; (4) the number of forward citations, adjusted for patent age; (5) the subset of forward citations consisting of self-citations, also adjusted for patent age; (6) the number of
claims; (7) the number of references to prior U.S. patents; (8) the
number of references to prior foreign patents; and (9) the number of
references to nonpatent prior art (i.e., “other publications”).
In the regression with technology areas, we included all of those
listed in the descriptive and bivariate statistics, except that we used the
total number of software patents and did not break the software category into subsets. In the regression with industry areas, we included
all of those listed in the descriptive and bivariate statistics.
II. RESULTS
A. The Characteristics of the Most-Litigated Patents
We begin by investigating the characteristics of the most-litigated
patents and comparing them to the control set of patents that were
litigated only once. The results are dramatic. The most-litigated patents differ fundamentally in virtually every respect from even the
once-litigated patents. We report these results in Tables 2 and 3.
Table 2 shows that the most-litigated patents made extraordinary
24
use of patent continuations. Litigated patents in the control set had
an average of two priority applications—the original application and
one continuation or divisional. Moreover, fully half of the patents in
25
the control set filed no continuation applications at all. By contrast,
the most-litigated patents had an average of 4.3 applications each, and
the median patent in this set had 3 applications.

24

For a discussion of patent continuations, see Mark A. Lemley & Kimberly A.
Moore, Ending Abuse of Patent Continuations, 84 B.U. L. REV. 63 (2004).
25
This explains the otherwise odd result that the median number of applications
filed is 1.5---exactly half of the patents had one application, and half had more than one.
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Table 2: Continuation Applications and Forward Citations
Number
of Nonprovisional
U.S. Apps. in
Chain

Total
Number of
Forward
Citations

Adjusted
Total
Number of
Forward
Citations

Total
Number
of SelfCitations

Adjusted
Number
of SelfCitations

Most-Litigated
Patents
Mean

4.32

32.25

-0.33

1.27

2.24

Median

3.00

15.50

-0.17

0.00

0.00

Standard
Deviation

4.85

42.42

1.02

5.29

11.20

Once-Litigated
Patents
Mean

2.01

14.07

-0.77

1.33

1.00

Median

1.50

6.00

-0.14

0.00

0.00

Standard
Deviation

1.40

23.18

1.74

2.74

1.71

Bivariate Comparison
(one sample t-test with log transformation)
p-value
Significant?

0.0001

0.0001

0.0001

0.0173

0.0001

Yes

Yes

Yes

Yes

Yes

Table 2 also shows differences in forward citations (i.e., citations received by subsequent patents referring back to the patent in question as
prior art), which economists have often identified as a measure of pa26
tent value. The results here are more complicated. As Hall, Jaffe, and
Trajtenberg have shown, just counting forward citations can be misleading because the older a patent is the more time others will have had to
27
cite it. The results also need to be adjusted because citation patterns
have changed over time. The base results in Table 2 show that the
26

A number of studies have used forward citations as evidence of patent value.
See, e.g., Bronwyn H. Hall, Adam Jaffe & Manuel Trajtenberg, Market Value and Patent
Citations, 36 RAND J. ECON. 16, 29-30 (2005) (finding that an extra citation per patent
increases a firm’s market value by three percent); Dietmar Harhoff et al., Citation Frequency and the Value of Patented Inventions, 81 REV. ECON. & STAT. 511, 515 (1999) (concluding from surveys in the United States and Germany that patents renewed to full
term are more frequently cited than those that lapse and that citation frequency increases with economic value for full-term patents); Manuel Trajtenberg, A Penny for Your
Quotes: Patent Citations and the Value of Innovations, 21 RAND J. ECON. 172, 172 (1990)
(demonstrating the use of patent counts weighted by citations as evidence of patent value); cf. Lanjouw & Schankerman, Characteristics, supra note 4, at 130 (finding that citations received predicted litigation when those citations were made by competitors).
27
Hall, Jaffee & Trajtenberg, supra note 26, at 30-31.
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most-litigated patents are cited more than twice as often as the controlset patents. After adjusting the number of forward citations received by
patents to account for their different ages, the differences between the
28
two data sets are significant to an exceptional degree. Table 2 also
shows significant differences in “self-citations,” a subset of forward citations that has been found to be an independent value indicator apart
29
from the set of overall forward citations of which they are a part.
The differences are even more dramatic when it comes to prior
art references (sometimes referred to as “backward citations”). These
28

The method of adjustment to account for the different ages of patents involves
placing each patent in the data set into a cohort of other patents in the data set that
were issued during the same year. Thus, each cohort is one year, although cohorts of
more than one year could be used if necessary even though that would decrease precision somewhat. The number of forward citations received by each patent is divided by
the average number of forward citations received by other patents in the same cohort.
This gives us the adjusted number of forward citations for that patent in the data set.
The process is repeated for every other patent in the same cohort and then repeated
for each patent in the other year cohorts. To obtain the adjusted number of forward citations for an entire data set, we then averaged the quantity of adjusted number of forward
citations received by all patents in the set. The method is from Bronwyn H. Hall, Adam B.
Jaffe & Manuel Trajtenberg, The NBER Patent-Citations Data File: Lessons, Insights, and Methodological Tools, in PATENTS, CITATIONS, & INNOVATIONS: A WINDOW ON THE KNOWLEDGE
ECONOMY 403, 434-37 (Adam B. Jaffe & Manuel Trajtenberg eds., 2002).
Because of the unusual skew in forward citations, the means for untransformed forward citations look nearly identical even though the differences in the distributions are
both dramatic and highly significant. As a result, we also report in Table 2 the logtransformed value for adjusted forward citations, which makes the differences quite clear.
29
Self-citations are references to the patent as prior art in subsequent patents issued to the same inventor or assignee. Self-citations have been identified as an independent indicator of private patent value apart from overall forward citations of which
the self-citations are a part. See, e.g., Hall et al., supra note 26, at 31-33 (finding selfcitation to be a highly significant indicator of market value). The apparent reason is
that self-citations provide evidence that the patent owner is building a portfolio of patents on related technologies, and a portfolio of patents often has a value that is greater than the sum of its parts. See, e.g., Gideon Parchomovsky & R. Polk Wagner, Patent
Portfolios, 154 U. PA. L. REV. 1, 5-6 (2005). Because there can be multiple inventors on
a patent, and because ownership of a patent can sometimes change after issuance,
there is occasionally difficulty in identifying a particular forward citation as a selfcitation. Thus, we used the following decision rule for identifying self-citations: a
forward citation is a self-citation if either (a) the owners of the main patent and the
forward citation are the same, or (b) the owners are different, the inventors in the main
patent and the forward citation are the same, and there are no co-inventors (i.e., no
other inventors). To apply this decision rule, we had to examine the front pages of
each of the 3419 patents that constituted forward citations to patents in our two data
sets. Economists do not examine individual forward citations and thus use a blunter
test to identify self-citations---a forward citation is a self-citation when the assignee
(owner) of the patent is the same in the instant patent and the forward citation. See,
e.g., Hall et al., supra note 28, at 424. This approach clearly does not capture any
nuance, but it has the advantage of being automatizable.

LEMLY FINAL REVISED READY TO PRINT.DOCX (DO NOT DELETE)

2009]

Extreme Value or Trolls on Top?

12/8/2009 12:20 PM

15

are references to prior U.S. and foreign patents as well as printed publications and claims. Table 3 presents these results. The mostlitigated patents have more than 50% more claims than the control
set—39.3 on average compared with 24.5 for once-litigated patents.
The number of claims is sometimes associated with patent value,
though two of the authors have elsewhere noted the complexity of the
30
claim count/value relationship. Much more significant is the differ31
ence in prior art citations.
The most-litigated patents cite nearly
three times as many U.S. and foreign patents as other litigated patents
and nearly ten times as many nonpatent prior art references as other
litigated patents. This is particularly notable given that litigated pa32
tents themselves cite much more prior art than unlitigated patents.
30

Allison et al., supra note 4, at 449 n.58 (noting that the number of claims in a
patent can depend on a number of factors correlated to value); see also John R. Allison
& Emerson H. Tiller, The Business Method Patent Myth, 18 BERKELEY TECH. L.J. 987,
1052-56 (2003) (reviewing the literature on numbers of claims as an indicator of patent value); Lanjouw & Schankerman, Characteristics, supra note 4, at 140-42 (discussing
patent claims as an underutilized indicator of patent value); Kimberly A. Moore, Xenophobia in American Courts, 97 NW. U. L. REV. 1497, 1544 (2003) (noting that, while the
number of claims has been shown to be an indicator of private value, the reason is not
that more claims cause the patent to have greater breadth (or scope) as economists
have asserted, as it is the generality of claim language that creates breadth); cf. John R. Allison & Mark A. Lemley, The Growing Complexity of the United States Patent System, 82 B.U. L.
REV. 77, 104 (2002) [hereinafter Allison & Lemley, Growing Complexity] (“[T]he number of
claims could also reflect resource constraints, drafting style, uncertainty about the law or the
significance of an invention, or a host of other factors that are not necessarily driven by patent value.”).
31
See, e.g., Allison & Tiller, supra note 30, at 1036-39 (arguing that there is a correlation between the number of prior art references and patent value); Allison et al., supra note 4, at 453 (finding a statistically significant relationship between prior art references and litigation); Harhoff et al., supra note 4, at 1360 (finding a relationship
between prior art references cited and other measures of patent value). But see Lanjouw & Schankerman, Characteristics, supra note 4, at 41 (“[A] litigated patent is likely
to cite fewer prior patents per claim than a randomly selected patent.”). The theory
behind the relationship of prior art references and value is that the more citations that
are considered during prosecution by the examiner, the less likely it is that some prior
art exists that will invalidate the patent. The more prior art considered, in other
words, the more likely a patent is to survive subsequent litigation. See, e.g., John R. Allison & Mark A. Lemley, Empirical Evidence on the Validity of Litigated Patents, 26 AIPLA
Q.J. 185, 232-34 (1998) (showing that courts are more likely to invalidate patents on
the basis of uncited prior art than on prior art cited to the PTO); Moore, supra note
30, at 1538 (“Patents that include more citations or more diverse citations are more
likely to be valid.”). Because lawyers know this, the value relationship may reflect not
only the strength of patents that cite a lot of prior art, but also efforts by applicants to
“bulletproof” patents they expect to litigate by citing a great deal of art.
32
Allison et al., supra note 4, at 453-55. Because many of the patents in this sample were issued before January 1, 2001, when the PTO began identifying examineradded prior art on the face of the patent, we were unable to determine whether it was
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All of these differences are significant at extraordinarily high confidence levels.
Table 3: Number of Claims and References

Number
of
Claims

Number of
References
to U.S.
Patents

Number of
References
to Foreign
Patents

Number of
Nonpatent
References
(Printed
Publications)

Most-Litigated
Patents
Mean
Median
Standard
Deviation

39.29
22.50

61.46
12.00

9.00
1.00

52.68
4.00

44.69

109.31

18.61

110.71

Once-Litigated
Patents
Mean

24.46

23.13

3.59

5.61

Median

19.00

12.50

0.00

0.00

Standard
Deviation

23.62

30.79

7.70

16.21

p-value
Significant?

Bivariate Comparison
(one sample t-test with log transformation)
0.0002
0.0149
0.0052
Yes

Yes

Yes

-10

1.33E
Yes

B. The Technologies and Industries of the Most-Litigated Patents
We also find dramatic differences between most-litigated and
once-litigated patents when it comes to the technologies they employ
and the industries with which they are associated. Prior work has
found that significant numbers of patents issue in a wide variety of
technology areas and industries, including mechanics, biotechnology,
33
semiconductors, and computer-related inventions, though this diver34
sity of technologies is a relatively recent phenomenon. In our 2004

the applicant or the examiner that provided most of this art. However, other work has
shown that virtually all nonpatent prior art (over ninety percent) is provided by applicants, not examiners. See Mark Lemley & Bhaven N. Sampat, Examiner Characteristics
and the Patent Grant Rate 10 (John M. Olin Program in Law & Econ., Working Paper
No. 369, 2009). Thus, it is quite likely that the disparity in nonpatent prior art citations is a result of applicant submissions, not examiner diligence.
33
See, e.g., Allison & Lemley, supra note 16, at 2113-15, 2148 tbl.1 (showing the distribution of studied patents among fourteen technology categories).
34
See, e.g., Allison & Lemley, Growing Complexity, supra note 30, at 93 & tbl.1, 94
(documenting the growing diversity of patented technologies).
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study, we found that patents were disproportionately more likely to be
litigated in some industries than in others, and that semiconductor
35
patents in particular were unlikely to be litigated.
We find even more significant differences in technology and industry areas between most-litigated and once-litigated patents. We report two sets of results: one by industry area and one by technology
area. As noted above, the two frequently diverge—a software invention may be used in any number of industries, some traditionally considered computer-related but others entirely divorced from it, such as
automobiles or bioinformatics. The results, reported as proportions of
the 106 patents in each data set involving the identified technology or
36
industry area, are presented in Tables 4 and 5 and Figures 1 and 2.

Figure 1: Technology Areas

80%
70%

Most-Litigated Patents

60%
50%

Once-Litigated Patents

40%
30%
20%
10%
0%

35

Allison et al., supra note 4, at 472.
A reminder—inventions can involve more than one industry or technology
class, so the proportions exceed 100%. We simply compared proportions between the
most-litigated and once-litigated data sets.
36
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Table 4: Technology-Areas Data
Most-Litigated
Patents

Once-Litigated
Patents

0.72

0.27

Bivariate Comparison
(one sample t-test with log
transformation)
Significant?

p-value
Software Total

-10

1.07341E

-06

1.21E

Pure Software

0.38

0.09

SoftwareBusMeth

0.15

0.04

Mechanical

0.08

0.53

2.54E

Electronics

0.01

0.25

2.6E

0.004809
-12

-07

Yes
Yes
Yes
Yes
Yes

Optics (other than imaging)

0.02

0.06

0.149394

No

Imaging

0.11

0.02

0.005684

Yes

Biotechnology

0.01

0.03

0.312702

No

Chemistry

0.19

0.18

0.859304

No

The most-litigated patents are overwhelmingly likely to be software
patents. Nearly three-fourths of the most-litigated patents are software
patents, compared with just over one-fourth of the once-litigated patents. Similarly, software-implemented business-method patents are
overrepresented in the most-litigated patents group (they comprise
15% of the most-litigated patents versus 4% of the least-litigated).
And imaging patents are much more heavily represented in the mostlitigated category (11% versus 2%) as well. By contrast, mechanical and
electronics patents make up the bulk of the once-litigated-patent cases,
but they are only of minor significance in the most-litigated-patent set.
Mechanical inventions make up only 8% of the most-litigated patents,
but 53% of the once-litigated patents; electronics inventions make up
only 1% of the most-litigated patents but fully 25% of the once-litigated
patents. Other industries, notably biotechnology and chemistry, do not
show significant differences between the two data sets.
We see similar variance when we move from the technology areas
to the industries. Figure 2 and Table 5 present the results by industry.
The computer industry is once again dominant in the most-litigatedpatent set; 72% of the most-litigated patents are in the computer industry, compared with 34% of the once-litigated patents. Telecommunications is similar; 34% of the most-litigated patents are in the
communications industry, compared with 8% of the once-litigated patents. By contrast, a variety of more traditional industries, including
electronics, medical, chemical, energy, consumer goods and services,
and construction are all significantly more likely to show up in the
once-litigated-patent set than in the most-litigated set.
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Figure 2: Industry Areas
80%

Most-Litigated
Most-Litigated Patents
Patents

70%

Once-Litigated Patents

60%
50%
40%
30%
20%
10%
0%

Table 5: Industry-Areas Data
Bivariate Comparison
(one sample t-test with
log transofrmation)

Most-Litigated
Patents

Once-Litigated
Patents

Computer

0.72

0.34

Semiconductors

0.05

0.05

1

No

Electronics

0.03

0.15

0.001773

Yes

p-value
-08

3.73E

Significant?
Yes

Medical

0.02

0.13

0.001808

Yes

Pharmaceutical

0.16

0.03

0.001004

Yes

Biotechnology

0.02

0.03

0.650849

No

0.003935

Yes

Chemical

0.00

0.03

Communications

0.34

0.08

Transportation

0.04

0.03

-06

2.12E

Yes

0.700709

No

Energy and
Utility Services

0.00

0.09

0.001197

Yes

Financial

0.02

0.00

0.155337

No

Consumer Goods
and Services

0.15

0.30

0.008647

Yes

Construction

0.00

0.05

0.023641

Yes
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In short, the most-litigated patents are disproportionately IT patents—software, software-implemented business methods, computer
industry, and telecommunications. Notably absent from this list is
the semiconductor industry; consistent with what Allison et al. found
in 2004, semiconductor inventions are a relatively minor percentage
37
of both data sets. Also surprising is the pharmaceutical industry,
which has a significant share of the most-litigated patents but perhaps less of a share than one might expect given their power in the
patent-reform debate.
C. The Owners of the Most-Litigated Patents
Finally, we collect a variety of information regarding the owners of
the patents in both the most-litigated and the once-litigated sets. To
begin, we must separate the initial owner of the patent from the owner when the lawsuit is filed because one of our findings is that more
than one-third of the litigated patents across both data sets were sold
38
to another owner after issue and before the first lawsuit was filed.
Small entities start out owning more once-litigated than mostlitigated patents: 57 of 106 once-litigated patents were originally assigned to small entities, compared to 40 of the most-litigated patents.
While one might conclude that small entities are more likely to be occasional users of the patent system, two problems complicate this conclusion. First, a large number of the most-litigated patents are owned
39
by a single entity—Ronald S. Katz Technology Licensing LLP. While
that company is most probably a “small entity,” defined as a company
employing fewer than 500 people, the patents were not filed with
small-entity status. To avoid skewing the data in either direction by
treating Katz patents either as large- or small-entity patents, we have
excluded them from the small-entity analysis entirely. That means
that the small-entity numbers are a larger share of the most-litigated
patents than the raw numbers suggest. Small entities owned 53.8% of
40
the once-litigated patents and 46.5% of the most-litigated patents.
37

Allison et al., supra note 4, at 472.
We found that 44 of the 106 most-litigated patents and 31 of the 106 oncelitigated patents were sold before litigation. The difference was not statistically significant, however, so we rely only on the aggregate numbers.
39
Katz had 20 of the top 106 most-litigated patents issued in his name. In fact, his
impact on the most-litigated patents is even greater, because at litigation he owned still
other patents acquired after issue.
40
Cf. Gwendolyn G. Ball & Jay P. Kesan, Transaction Costs and Trolls: Strategic Behavior by
Individual Inventors, Small Firms, and Entrepreneurs in Patent Litigation 14 (Univ. Ill. Law & Econ.
38
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That is not the end of the story, however, because the owner of
the patent at issue is not always the owner of the patent when the suit
is filed. Indeed, we find that 44 of the 106 most-litigated patents and
31 of the 106 once-litigated patents are assigned to another entity be41
fore the first lawsuit is filed. In Table 6 and Figure 3, we relate the
entity size at issue to the likelihood of assignment before litigation.
Figure 3: Entity-Assignment Matrix
Excluding Patents Originally Issued to Katz
100%
90%

Small Entity,
Not Assigned
Before

80%
70%

Small Entity,
Assigned
Before

60%

Small Entity,
Assigned
Before

50%
40%

Small Entity,
Not Assigned
Before

Large Entity,
Not Assigned
Before
Large Entity,
Not Assigned
Before

30%
20%
10%

Large Entity,
Assigned
Before

0%
Most-Asserted
Most-Asserted Set
Set

Large Entity,
Assigned
Before

Once-Asserted Set
Set
Once-Asserted

Paper Series, Research Paper Series No. LE09-005, 2009), available at
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1337166 (finding that small firms are
frequent patent litigants).
41
This is consistent with Judge Kimberly Moore’s finding that assignments of litigated patents are quite common. See Kimberly A. Moore, Populism and Patents, 82 N.Y.U.
L. REV. 69, 92-93 (2007); see also Carlos J. Serrano, The Dynamics of the Transfer and Renewal
of Patents 3 (Nat’l Bureau of Econ. Research, Working Paper No. 13938, 2008) (finding
that the likelihood that a patent will be transferred increases with indicia of value).
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Table 6: Entity-Assignment Matrix Data

Assigned
Before
Litigation
Not Assigned
Before
Litigation

Most-Asserted Set

Once-Asserted Set

LargeEntity
Owner

SmallEntity
Owner

LargeEntity
Owner

SmallEntity
Owner

23

21

12

19

43

19

37

38

Notably, once assignments are taken into account, it seems that
small entities that keep rather than sell their patents tend to litigate
less often than either large entities or purchasers of small-entity patents. The fact that assigned patents are more likely to be the mostlitigated patents is also consistent with the idea that the most-litigated
patents are also the most valuable, since they are more likely to have
42
been sold.
Next, we evaluate the nature of the patent owners in both sets.
One of the biggest policy debates in patent reform has been over the
nature and extent of “patent trolls.” As noted in Part I, we divide the
patent plaintiffs in our data sets into twelve different categories. We
present the results of that categorization in Table 7 and Figure 4.

42

An alternative explanation, however, is that once a company pays money to buy
a patent, it is more likely to enforce that patent since it wants a return on its investment. Similarly, the correlation between value and assignment may reflect the nature
of the acquiring entities, at least for a given subset of cases. An entity purchasing thirdparty patents to assert will presumably do precisely that. Moreover, at least some patent holders may create special-purpose entities immediately prior to, and for, litigation. On the other hand, one must assume that an acquirer will evaluate the likely value of patents before buying them and will not knowingly purchase patents that are
either of highly dubious validity or of such narrow scope as to be of little use.
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Figure 4: Entity Status
90
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Most-Litigated Patents

70
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Table 7: Entity-Status Data
MostLitigated
Patents

OnceLitigated
Patents

Entity Class 1 (Acquired patents)

12

3

Entity Class 2 (University heritage or tie)

0

1

Entity Class 3 (Failed startup)

0

3

Entity Class 4 (Corporate heritage)

0

1

Entity Class 5 (Individual-inventor-started company)

43

7

Entity Class 6 (University/Government/NGO)

0

1

Entity Class 7 (Startup, pre-product)

0

0

Entity Class 8 (Product company)

47

85

Entity Class 9 (Individual)

1

0

Entity Class 10 (Undetermined)

3

4

Entity Class 11 (Industry consortium)

0

1

Entity Class 12 (IP subsidiary of product company)

0

0

106

106

Entity Classes

Total
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The differences are dramatic. Once the few entities whose status
we could not determine (three of the most-litigated patents and four
of the once-litigated patents) are excluded, traditional product companies—those that are participants in the market in which they are
enforcing the patent—represent 83.3% of the once-litigated patents
but only 45.6% of the most-litigated patents. If one views all nonpracticing entities as patent trolls, a view with which we do not necessarily
43
agree, trolls hold a significant share of the most important patents,
44
but a much smaller share of “ordinary” once-litigated patents. The
most-litigated patents, despite being small in number compared to the
total number of patents issued, are disproportionately important to the
patent system because of the volume of litigation they generate. Nonetheless, it is worth keeping in mind that the 2987 infringement suits
filed on the 106 most-litigated patents still represent only about 14% of
45
the patent suits filed from 2000 through 2007.
Nonpracticing entities in the most-litigated-patent set fall almost
entirely into only two classes: licensing companies in the business of
buying up and enforcing patents (“trolls” by virtually anyone’s definition) and companies started by an inventor that do not make products. Licensing companies account for 11.7% of the most-litigatedpatent suits, and inventor companies account for 41.7% of those suits.
Only one patentee in this group—an individual litigant—falls into any
other category. By contrast, the ecology of once-litigated patents is
somewhat more diverse; that data set includes suits by universities,
university spin-outs, failed start-ups, companies that once sold products but no longer do, and industry consortia. None represents a
large percentage of the set of once-litigated patents.
The disparity is even greater than these data suggest. Each patent
in the control set has been litigated only once, meaning that each patent has an equal effect on the overall distribution. By contrast, the
most-litigated patents include some patents litigated eight times and
46
others litigated ninety-seven times. Weighting entity status by the
43

See Mark A. Lemley, Are Universities Patent Trolls?, 18 FORDHAM INTELL. PROP.
MEDIA & ENT. L.J. 611, 612 (2008) (arguing that universities, although nonpracticing
patent owners, are not necessarily patent trolls).
44
The differences we report are statistically significant at a 95% or greater confidence level for class 1, and at a 99% confidence level for classes 5 and 8.
45
See Stanford IP Litigation Clearinghouse, http://lexmachina.stanford.edu (last visited
Oct. 15, 2009) (reporting that 13,793 total patent suits were filed between 2003 and 2007 inclusive). A list of the most-litigated patents and the number of suits in the database is attached as the Appendix.
46
See infra Appendix.
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number of lawsuits gives us a somewhat different story, one depicted
in Table 8 and Figure 5.
Figure 5: Number of Lawsuits in
Most-Litigated Patents, by Entity Class

Number of Lawsuits
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Table 8: Most-Litigated Patents by Status

MostLitigated
Patents

Number of
Suits in
Most-Litigated
Patents

Entity Class 1 (Acquired patents)

11

199

Entity Class 2 (University heritage or tie)

0

0

Entity Class 3 (Failed startup)

0

0

Entity Class 4 (Corporate heritage)

0

0

Entity Class 5 (Individual-inventor-started company)

41

2198

Entity Class 6 (University/Government/NGO)

0

0

Entity Class 7 (Startup, pre-product)

0

0

Entity Class 8 (Product company)

51

544

Entity Class 9 (Individual)

0

11

Entity Class 10 (Undetermined)

3

35

Entity Class 11 (Industry consortium)

0

0

Entity Class 12 (IP subsidiary of product company)

0

0

106

2987

Entity Classes

Total
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Once we take account of the number of suits, the share of suits by
product companies falls to 18.4%—showing that more than 80% of the
47
most-litigated-patent suits are filed by NPEs. Most are filed by inventor-owned or inventor-developed companies, which account for 74.4%
of the most-litigated-patent lawsuits. Further, the share of suits filed by
licensing shops actually falls to 6.7% of all suits. Nonpracticing entities
are a small share of once-litigated patents, but they thus represent an
overwhelming share of the suits filed on the most-litigated patents.
D. The Katz Effect
It is worth mentioning the outsized role played here by one patent
plaintiff, Ronald Katz. He owns a large percentage of the mostlitigated patents, including most of the top thirty patents. Roughly
60% (1789 of 2987) of the patent-lawsuit combinations in the mostlitigated set are Katz-related lawsuits. There is no question that Katz is
an outlier. We considered removing his suits from our results but decided against it, as the most-litigated patents are all outliers in some
sense and removing Katz would skew our data. Katz is a product of
the current patent system, and the Katzes of the world should be considered in evaluating the effects of that system.
E. Logistic Regression
In both the technology-area and industry-area regressions, we
found three continuous variables to be significant or highly significant
despite the existence of substantial correlations among many variables: (1) the number of U.S. nonprovisional applications leading
48
to the particular patent; (2) the number of references to prior U.S.
49
patents; and (3) the number of references to nonpatent prior art
50
(i.e., “printed publications”). In the technology-area logistic regression, we found a high degree of significance for the software
(p = 0.0024) and mechanical (p = 0.0004) areas. In the industry-area
logistic regression, we found exceptionally high levels of significance for
51
the computer (p < 0.0001) and pharmaceutical (p < 0.0001) areas.

47

This may overstate the role played by NPEs, however, because many of those
suits involve more than one patent in our data set.
48
Technology-area regression p = 0.0303; industry-area regression p = 0.0359.
49
Technology-area regression p = 0.0223; industry-area regression p = 0.0061.
50
Technology-area regression p = 0.0282; industry-area regression p = 0.0062.
51
The full results of the logistic regressions are available from the authors on request.
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Given the large number of correlated variables in patent data, it
is quite meaningful that we found significance in the three continuous
variables in both regressions. The more interactions there are among
variables, the more difficult it is to tease out predictive power in a
multiple regression.
In addition to the unavoidable correlations among many patent
characteristics, the very nature of the question we are asking places
some limitations on the logistic regressions. First, the nature of our
inquiry into the most-litigated patents necessarily means that we have
a relatively small number of observations. Data sets of 106 observations
each are large enough for statistical analysis, but when combined with
the fact of unavoidable interactions among many variables, larger data
sets would allow for stronger results. With larger numbers of observations, we would almost certainly find significance with more variables in
the regressions. There is, however, no way to make them larger. We
are intentionally looking at “upper-outlier patents.” Moreover, when we
divide the patents in our data sets into technology and industry areas,
we necessarily reduce the number of observations even further. This
fact makes it even more remarkable that significance in the regressions
was found in two technology areas and two industry areas.
In addition, the number of interactions among variables was increased by the fact that, as in our previous studies, we did not treat
technology or industry areas as necessarily being mutually exclusive.
This reflects the reality of modern inventions: any attempt to assign
many patented inventions to a single technology or industry area is
completely unrealistic and unjustifiable. However, the fact that a single
patent may belong in more than one technology or industry area does
further increase the number of interactions among these variables.

52

Many patent characteristics are necessarily correlated rather highly, such as the
number of claims, various types of prior art references, number of U.S. applications
leading to a particular patent, and number of forward citations. This correlation has a
common cause: applicants for certain patents perceive in advance that the patents
likely will have value to them, that they will be important, and even that they are more
likely to be litigated, and this perception often leads the applicants to make such patents stronger and broader by drafting more claims, finding and citing more prior art,
and actively crafting the patent using continuation applications. Their actions, in turn,
tend to create private value for the patents. Applicants do not have the same degree of
control over the number of forward citations as they do over other patent metrics, except for self-citations in their own later patents (which, as previously explained, is itself
an independent indicator of value). However, these are patents that the owners are
more likely to assert through litigation or licensing, and they get more attention, leading
to more forward citations by others in later patents. As a consequence, the number of
forward citations is also correlated with the internal patent characteristics noted above.

LEMLY FINAL REVISED READY TO PRINT.DOCX (DO NOT DELETE)

University of Pennsylvania Law Review

28

12/8/2009 12:20 PM

[Vol. 158: 1

In the end, because of the very nature of the questions we ask and
the unavoidable interactions in our data, our results may be portrayed
less accurately by the logistic regressions than by the descriptive statistics and bivariate comparisons. We have accordingly emphasized
those conclusions in the Part that follows.
III. IMPLICATIONS
In this Part, we draw a number of possible implications from the
data. Notably, there are different ways to understand our data, and,
depending on one’s predisposition, the data might point to different
policy conclusions. We seek to identify some of the most likely implications in this Part.
A. Extreme Value?
The first thing that stands out is the powerful evidence that the
most-litigated patents have different, clearly identifiable characteristics
that distinguish them from once-litigated patents (and distinguish
them even more from ordinary, nonlitigated patents). Notably, the
characteristics that distinguish the most-litigated patents from other
patents are also the ones that researchers have long used to identify
the most-valuable patents: more claims, more prior art citations, more
forward citations, a higher likelihood of assignment between issue and
litigation, and larger numbers of continuation applications. A reasonable conclusion, therefore, is that the most-litigated patents are also the most-valuable patents. Allison et al. drew this conclusion for
the general class of litigated patents (i.e., patents that had been liti53
gated at least once). Our data seem to strengthen that conclusion
substantially. While one might question whether litigation was actually an indicator of value in all cases, the fact that more litigation is
strongly correlated with the indicia of value suggests that the intuitive
54
relationship between value and litigation is indeed the right one.
53

Allison et al., supra note 4, at 439-43.
This is not to suggest, however, that the objective measures of value accurately
capture all, or even most, of the value of patents; they are necessarily imperfect indicators of that value. See David E. Adelman & Kathryn L. DeAngelis, Patent Metrics: The
Mismeasure of Innovation in the Biotech Patent Debate, 85 TEX. L. REV. 1677, 1680 (2007)
(“[T]he misuse of patent metrics has both fostered dire predictions and created unrealistic expectations about the capacity of patent data to guide policy.”). But the fact that
they are not perfect predictors does not render them worthless. See Allison & Sager,
supra note 4, at 1794 (concluding that, despite some imperfections, patent characteristics can be useful in identifying valuable patents).
54
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The fact that the most-litigated patents are disproportionately
owned by nonpracticing entities, coupled with our suggestion that the
most-litigated patents are the most valuable ones, might lead one to
conclude that nonpracticing entities produce the most important patents and therefore are owed more respect than the current patent
system (and certainly patent reformers) gives them. This reasoning
might also support a subsidiary conclusion that continuation applica55
tions are necessary to support the most important patents.
We acknowledge that these are possible implications of our results. But there are reasons to be cautious in drawing these conclusions. The value we identify in this Article is not social value but pri56
vate value. Our results suggest that having more claims, more prior
art citations, and more continuation applications leads to stronger patents, and a first-order assessment might suggest that stronger patents
are good. But that does not mean that those patents are necessarily
better for society or even valid. It may simply mean that those patents
are optimized for litigation, because they are better protected against
57
the vagaries of claim construction and against validity challenges
58
based on uncited prior art. And because of the well-known constraints under which the PTO operates, it may even be that the PTO is
worse at assessing larger, more complex patents in the limited time
59
that examiners can devote to those patents.
Whether the most-litigated patents represent the most important
inventions or just the most valuable rights to exclude, the fact that the
patents that are likely to generate the most litigation have common
55

But see Lemley & Moore, supra note 24, at 71-83 (arguing that continuations are
mostly unnecessary and do more harm than good).
56
On the difference, see Allison et al., supra note 4, at 439-40.
57
Burk and Lemley argue that modern claim construction can systematically disadvantage patentees since even one error in claim drafting or one lost claimconstruction fight may result in a finding of either invalidity or noninfringement. Dan
L. Burk & Mark A. Lemley, Fence Posts or Sign Posts? Rethinking Patent Claim Construction,
157 U. PA. L. REV. 1743, 1763 (2009). Drafting more claims hedges against this risk
by giving the patentee multiple shots at an error-free claim. Continuations also hedge
against this risk by allowing patentees to rewrite their claims after the fact.
58
See Allison & Lemley, supra note 31, at 231-34 (finding that it is much harder to
invalidate patents based on art that was cited to the PTO, leading to the possibility of
“bulletproofing” a patent application by including as much prior art as possible). Relatedly, a sea of citations may actually diminish the PTO’s ability to analyze invalidity with
respect to the most salient prior art included therein, since examiners operate under
severe time constraints and are not given more time to examine applications just because they include more prior art.
59
We test this hypothesis in an upcoming companion paper that investigates the
outcomes of the most-litigated-patent cases. See supra note 14 and accompanying text.
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characteristics, identifiable before or during patent prosecution, has
important implications for reforming the patent-prosecution process.
One of us argued in 2001 that it would not be cost-effective for the PTO
60
to achieve 100% accuracy in granting or denying every patent. Nonetheless, it would surely be desirable to improve the accuracy of PTO decisions in both directions if it could be done without substantial addi61
tional expense. And if we have good information on which patents
are likely to turn out to be important, at least in the sense that their validity is going to matter, we can use that information to focus more attention on those applications during the prosecution process. Patent
62
reformers have, for example, proposed post-grant opposition, a tiered
63
64
review or “gold-plating” system, and outside peer review of patents.
Each of those proposals, to be workable, requires the selection of certain patents or applications on which to focus additional attention. The

60

Lemley, supra note 5, at 1508-10.
See, e.g., Joseph Farrell & Carl Shapiro, How Strong Are Weak Patents?, 98 AM.
ECON. REV. 1347, 1362 (2008) (noting that “weak” patents of questionable validity are
very costly to society and urging a “targeted application of resources” to improve the
patent review process); Joseph Farrell & Robert P. Merges, Incentives to Challenge and
Defend Patents: Why Litigation Won’t Reliably Fix Patent Office Errors and Why Administrative Patent Review Might Help, 19 BERKELEY TECH. L.J. 943, 960-64 (2004) (arguing that
litigation does not efficiently correct PTO mistakes and urging better funding and improved processes for patent review).
62
See, e.g., Mark D. Janis, Rethinking Reexamination: Toward a Viable Administrative
Revocation System for U.S. Patent Law, 11 HARV. J.L. & TECH. 1, 118-21 (1997) (recommending the adoption of a post-grant opposition mechanism incorporating lessons
learned from U.S. and European experience); Robert P. Merges, As Many as Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and Patent System Reform,
14 BERKELEY TECH. L.J. 577, 614 (1999) (advocating a “coherent, efficient opposition
procedure”); Craig Allen Nard, Certainty, Fence Building, and the Useful Arts, 74 IND. L.J.
759, 764 (1999) (proposing “the implementation of a post-grant opposition proceeding”); J.H. Reichman, From Free Riders to Fair Followers: Global Competition Under the
TRIPS Agreement, 29 N.Y.U. J. INT’L L. & POL. 11, 31 (1997) (“A national opposition system seems uniformly advisable.”); John R. Thomas, Collusion and Collective Action in the
Patent System: A Proposal for Patent Bounties, 2001 U. ILL. L. REV. 305, 326-30 (“The general acknowledgment of the wisdom of oppositions is striking.”)
63
See Doug Lichtman & Mark A. Lemley, Rethinking Patent Law’s Presumption of Validity, 60 STAN. L. REV. 45, 61-63 (2007) (arguing in support of an additional, optional
“gold-plated” patent-review process); Mark Lemley, Doug Lichtman & Bhaven Sampat,
What to Do About Bad Patents, REG., Winter 2005-2006, at 10, 10-12 (advocating for a twotiered patent review system). While one might view applicant bulletproofing as a form
of “gold plating,” the latter term refers to a proposal that the PTO devote additional
resources to examine certain applications and award a patent that has correspondingly
higher deference.
64
See Beth Simone Noveck, “Peer to Patent”: Collective Intelligence, Open Review, and
Patent Reform, 20 HARV. J.L. & TECH. 123, 143-51 (2006) (supporting an open peerreview framework for patent reviews).
61
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value data may give us a means to select applications for additional review. It could also be systematized within the PTO, for example by replacing the “one size fits all” allocation of examiner time with a complexity-weighting system that gives examiners more time and more
credit for evaluating the most complex (and most valuable) applications. Moreover, the ability to identify the most valuable patents in advance may allow companies to focus their attention on smaller sets of patents with which they should be concerned when they invent in the same
or a related area. It may also provide investors with more relevant information when deciding whether to help fund a start-up, take a security
65
interest in a patent for a loan, or make some other investment decision.
The data also suggest substantial variation by technology area and
industry area in how patent litigation works. That itself should come
as no surprise; Burk and Lemley have documented the many ways in
which both patent law and innovation incentives are industry specific,
and the congressional debates over patent reform have pitted differ66
ent industries against each other on issue after issue. But the disproportionate representation of software, telecommunications, and
business-method patents among the most-litigated patents might suggest that it is appropriate to pay more attention to patents in those
technologies and industries, both in court and at the PTO, just as the
importance of patents with multiple claims and prior art citations suggests that those patents are more important than the average patent.
Here too we urge caution, however: While the most-litigated patents are
disproportionately IT patents, there are unquestionably pharmaceutical
patents whose value exceeds that of any patent in the IT industry. The
regulated nature of the biomedical industries may be limiting the number of lawsuits in the pharmaceutical and biotechnology industries.
B. Trolls on Top?
The other important difference evident from this data is the prevalence of nonpracticing entities in the most-litigated patents. Patent
reform debates have, perhaps unfortunately, focused a great deal of
attention on “patent trolls.” There is substantial disagreement as to
whether trolls exist and how significant a role they play in patent liti65

See Allison & Sager, supra note 4, at 1787-88 (describing how prospective investors may sift through a set of patents looking for ones of value).
66
See BURK & LEMLEY, supra note 1, at 49-66 (documenting industry differences in
innovation and patenting); see also Josh Lerner, The Litigation of Financial Innovations 2
(Nat’l Bureau of Econ. Research, Working Paper No. 14324, 2008) (finding that financial-services patents are litigated 27 to 39 times more than ordinary patents).

LEMLY FINAL REVISED READY TO PRINT.DOCX (DO NOT DELETE)

University of Pennsylvania Law Review

32

12/8/2009 12:20 PM

[Vol. 158: 1

67

gation.
Our data shed significant light on this question, though
readers may disagree on how to interpret that data.
Nonpracticing entities are clearly an important phenomenon in
the modern patent system. While they account for only about 16% of
the once-litigated patents, they represent over 80% of the suits filed
involving the most-litigated patents and own more than 50% of the
68
most-litigated patents themselves. Clearly, then, the role of nonpracticing entities in the modern patent system cannot be dismissed and
should not be diminished.
Whether this represents a flood of patent trolls depends critically
on how one defines the term “patent troll.” If a patent troll is anyone
who sues to enforce a patent that she does not practice, trolls are indeed rampant among the most-litigated patents. But if we limit the
definition to companies enforcing patents that cover inventions they
did not themselves develop, the number of patent trolls drops dramatically, to 12% of the patents and 7% of the lawsuits. And even if the
reader decides that trolls are rampant, that fact informs policy debates
over patent reform but does not itself tell us whether to celebrate or
deplore the role of patent trolls.
One of the authors has argued that we should not focus so much
attention on labeling particular plaintiffs as trolls or not, but instead
on making sure that the patent rules provide patentees of all types fair
69
compensation but not opportunities for holdup. Even if we are not
to create troll-specific rules, however, our findings here are important
because they suggest that the remedy rules that do depend on the
70
plaintiff’s status, such as entitlement to injunctive relief and lost71
profits damages, are critically important and need to be evaluated in
67

See supra note 2 and accompanying text.
Colleen Chien studied the percentage of all suits filed by trolls. In defining only
a subset of nonpracticing entities as trolls and excluding lawsuits by individuals, she
found that while 17% of suits were filed by trolls, those suits accounted for 28% of the
defendants in patent cases—a share that has continued to rise over time. Colleen V.
Chien, Of Trolls, Davids, Goliaths, and Kings: Narratives and Evidence in the Litigation of
High-Tech Patents, 87 N.C. L. REV. 1571, 1608-11 (2009).
69
See Lemley, supra note 43, at 630-31 (arguing that identifying trolls is not as important as preventing abuses of the patent system by any plaintiff).
70
See eBay Inc. v. MercExchange L.L.C., 547 U.S. 388, 393-94 (2006) (requiring
proof of irreparable injury before granting injunctions in patent cases).
71
See, e.g., BIC Leisure Prods., Inc. v. Windsurfing Int’l, Inc., 1 F.3d 1214, 1219,
1223 (Fed. Cir. 1993) (reversing an award of lost profits because the patentee and the
infringer did not compete); cf. Del Mar Avionics, Inc. v. Quinton Instrument Co., 836
F.2d 1320, 1326 (Fed. Cir. 1987) (describing the “general rule” that patentees producing the patented item are entitled to lost-profits damages); John E. Dubiansky, An
68
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the context of a world in which many of the most significant patent
lawsuits are not those filed by practicing entities against competitors.
72

APPENDIX: THE MOST-LITIGATED PATENTS
Patent
Number

Assignee/
Applicant Name

Earliest Case Title

Plaintiff

Entity
Class

5132992

Paul Yurt &
Browne H. Lee

Acacia Media Tech. Co. v.
New Destiny Internet

Acacia Media
Tech. Co.

1

6144702

Greenwich Information Techs., LLC

Acacia Media Tech. Co. v.
New Destiny Internet

Acacia Media
Tech. Co.

1

5734961

Genese

Antor Media Corp. v.
Audiogalaxy, Inc.

Antor Media
Corp.

10

4924257

Jain Kanti

Anvik Corp. v. Nikon Precision, Inc.

Anvik Corp.

8

5285236

Jain Kanti

Anvik Corp. v. Nikon Precision, Inc.

Anvik Corp.

8

5291240

Anvik Corp.

Anvik Corp. v. Nikon Precision, Inc.

Anvik Corp.

8

5721606

Jain Kanti

Anvik Corp. v. Nikon Precision, Inc.

Anvik Corp.

8

5897986

Anvik Corp.

Anvik Corp. v. Nikon Precision, Inc.

Anvik Corp.

8

6748318

Arrival Star, Inc.

Arrival Star, Inc. v. Nistevo Corp.

Arrival Star, Inc.

1

6904359

Arrival Star, Inc.

Arrival Star, Inc. v.
Pilot Air Freight Corp.

Arrival Star, Inc.

1

5738872

Hoechst Marion
Roussel, Inc.

Aventis Pharm. v. Barr Labs.

Aventis Pharm.

8

5855912

Hoechst Marion
Roussel, Inc.

Aventis Pharm. v. Barr Labs.

Aventis Pharm.

8

6037353

Hoechst Marion
Roussel, Inc.

Aventis Pharm. v. Barr Labs.

Aventis Pharm.

8

6113942

Aventis Pharm., Inc.

Aventis Pharm. v. Barr Labs.

Aventis Pharm.

8

6187791

Merrell Pharm., Inc.

Aventis Pharm. v. Barr Labs.

Aventis Pharm.

8

6399632

Merrell Pharm., Inc.

Aventis Pharm. v. Barr Labs.

Aventis Pharm.

8

6482516

Banner
Pharmacaps, Inc.

Banner Pharmacaps, Inc. v.
Perrigo Co.

Banner
Pharmacaps, Inc.

8

6044362

Alan R. Neely

BCE Emergis Tech. v. EDOCS, Inc.

BCE Emergis
Tech.

8

6374229

Billingnetwork.com,
Inc.

Billingnetwork.com v.
Advanced Healthcare

Billingnetwork.com

8

5951643

NCR Corp.

Boardman Molded Prods., Inc. v.
Mats, Inc.

Boardman
Molded Prods.,
Inc.

8

Analysis for the Valuation of Venture Capital-Funded Startup Firm Patents, 12 B.U. J. SCI. &
TECH. L. 170, 177 (2006) (“In the licensing context, however, the patent owner is not
engaged in an enterprise which utilizes the patent. Consequentially, the owner has no
profits to have lost, and is only eligible to receive a reasonable royalty.”).
72
The count here is based on the number of lawsuits in which the patent could be
verified using IPLC data. Because some lawsuits, including some of Katz’s lawsuits, involve more than one patent, the actual number of cases filed by the plaintiffs identified
here is smaller than simply adding the number of suits for each patent would suggest.
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Earliest Case Title

Plaintiff

NCR Corp.

Boardman Molded Prods., Inc. v.
Mats, Inc.

Boardman
Molded Prods.,
Inc.

8

6169997

NCR Corp.

Boardman Molded Prods., Inc. v.
Mats, Inc.

Boardman
Molded Prods.,
Inc.

8

6480855

NCR Corp.

Boardman Molded Prods., Inc. v.
Mats, Inc.

Boardman
Molded Prods.,
Inc.

8

6502096

NCR Corp.

Boardman Molded Prods., Inc. v.
Mats, Inc.

Boardman
Molded Prods.,
Inc.

8

5933630

Acceleration
Software Int’l Corp.

Computer Acceleration Corp. v.
Microsoft Corp.

Computer Acceleration Corp.

1

5883964

Cygnus Telecomms.
Tech., LLC

Cygnus Telecomms. Tech. v. Int’l Telec
Ltd.

Cygnus
Telecomms.
Tech.

1

6035027

Cygnus Telecomms.
Tech., LLC

Cygnus Telecomms. Tech. v. Int’l Telec
Ltd.

Cygnus
Telecomms.
Tech.

1

5910988

CSP Holdings, Inc.

Datatreasury Corp. v. First Data Corp.

Datatreasury
Corp.

1

6032137

CSP Holdings, LLC

Datatreasury Corp. v. First Data Corp.

Datatreasury
Corp.

1

4975950

Stephen A. Lentz

Digital Dev. Corp. v.
Asus Computer Int’l

Digital Dev.
Corp.

10

5121345

Stephen A. Lentz

Digital Dev. Corp. v.
Asus Computer Int’l

Digital Dev.
Corp.

10

6295530

Jonathan M.
Bradshaw

East Mfg. Corp. v. Titan Trailers, Inc.

East Mfg. Corp.

8

6961737

Ablaise Ltd.

East Mfg. Corp. v. Titan Trailers, Inc.

East Mfg. Corp.

8

7075673

EON-Net, LP

Eon-Net, LP v. Flagstar Bancorp

Eon-Net, LP

5

6683697

Millenium, LP

Eon-Net, LP v. Black Hound New York

Eon-Net, LP

5

5313229

Federico G.
Gilligan &
Fernando D. Falcon

F & G Research, Inc. v. Kye Int’l

F & G Research,
Inc.

5

8

4787722

Fresnel Techs., Inc.

Fresnel Techs. v. Rokonet Indus.

Fresnel Techs.

RE35534

Fresnel Techs., Inc.

Fresnel Techs. v. Rokonet Indus.

Fresnel Techs.

8

6294196

Hoffmann-La
Roche, Inc.

Hoffman-La Roche, Inc. v.
Gate Pharm.

Hoffman-La
Roche, Inc.

8

6298862

Laughlin Prods.,
Inc.

In re Laughlin Prods., Inc.,
Patent Litig.

Laughlin Prods.,
Inc.

5

6464703

Elektromedizin
GmbH

In re Katz Interactive Call
Processing Patent Litig.

Ronald A. Katz
Tech. Licensing,
LP

5

4663318

Bonnie Davis

In re '318 Patent Infringement Litig.

Barr Labs.

8

5922333

Laughlin Prods.,
Inc.

Laughlin Prods., Inc. v. TRB Group

Laughlin Prods.,
Inc.

5

7040022

Great Neck Saw
Mfrs., Inc.

Laughlin Prods., Inc. v. Binder

Laughlin Prods.,
Inc.

5
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Patent
Number

Assignee/
Applicant Name

Earliest Case Title

Plaintiff

Entity
Class

5425085

Rates Tech. Inc.

Laughlin Prods., Inc. v. Bariana

Laughlin Prods.,
Inc.

5

6474343

Laughlin Prods.,
Inc.

Laughlin Prods., Inc. v. ETS, Inc.

Laughlin Prods.,
Inc.

5

5258855

System X, LP

Millennium, LP v.
Hyland Software, Inc.

Millennium, LP

5

5369508

System X, LP

Millennium, LP v.
Hyland Software, Inc.

Millennium, LP

5

5625465

Int’l Patent
Holdings Ltd.

Millennium, LP v.
Hyland Software, Inc.

Millennium, LP

5

5768416

Millennium, LP

Millennium, LP v.
Hyland Software, Inc.

Millennium, LP

5

6094505

Millennium, LP

Millennium, LP v.
Hyland Software, Inc.

Millennium, LP

5

RE39247

Monsanto Tech.,
LLC

Monsanto Co. v. SUGGS

Monsanto Co.

8

5352605

Monsanto Co.

Monsanto Co. v. McFarling

Monsanto Co.

8

5699526

NCR Corp.

NCR Corp. v. Microstrategy Inc.

NCR Corp.

8

6026403

NCR Corp.

NCR Corp. v. Microstrategy Inc.

NCR Corp.

8

5137342

Oakley, Inc.

Oakley, Inc. v. Pacific Sunwear

Oakley, Inc.

8

5367627

Clear with
Computers, Inc.

Orion IP, LLC v. Staples, Inc.

Orion IP, LLC

1

5615342

Clear with
Computers, Inc.

Orion IP, LLC v. Staples, Inc.

Orion IP, LLC

1

5053407

Daiichi Pharm. Co.,
Ltd.

Ortho-McNeil Pharm. v. Mylan Labs.

Ortho-McNeil
Pharm.

8

5991791

NCR Corp.

Overstock.com v. NCR

Overstock.com

8

6253203

NCR Corp.

Overstock.com v. NCR

Overstock.com

8

6777095

Parker-Hannifin
Corp.

Parker-Hannifin Corp. v.
Zippertubing (Japan) Ltd.

Parker-Hannifin
Corp.

8

5809336

Patriot Scientific
Corp.

Patriot Scientific Corp. v.
Sony Corp. of Am.

Patriot Scientific
Corp.

8

6298341

RareDomains.com,
LLC

RareDomains.com, LLC v. Verio, Inc.

RareDomains.com, LLC

8

5519769

Rates Tech., Inc.

Rates Tech., Inc. v. Tech. Arts, Inc.

Rates Tech., Inc.

1

5243627

AT&T Bell Labs.

Rembrandt Techs., LP v.
Comcast Corp.

Rembrandt
Techs., LP

1

6570967

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Alltel Corp.

Ronald A. Katz
Tech. Licensing,
LP

5

5109404

First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP v.
Ahold USA Inc.

Ronald A. Katz
Tech. Licensing,
LP

5

4792968

FDR Interactive
Techs.

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

4930150

First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5
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First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5255309

First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5259023

First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5351285

First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5561707

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5684863

Ronald A. Katz,
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5787156

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5828734

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5835576

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5898762

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5917893

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5974120

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6035021

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6044135

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6148065

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6292547

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6335965

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6424703

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5
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6434223

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6512415

Ronald A. Katz
Tech. Licensing LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

6678360

Ronald A. Katz
Tech. Licensing, LP

Ronald A. Katz Tech. Licensing, LP v.
Citibank

Ronald A. Katz
Tech. Licensing,
LP

5

5048075

First Data Res., Inc.

Ronald A. Katz Tech. Licensing, LP,
v. Am. Airlines, Inc.

Ronald A. Katz
Tech. Licensing,
LP,

5

5338874

Tanaka Kikinzoku
Kogyo K.K.

Sanofi-Aventis U.S., LLC v. Sandoz,
Inc.

Sanofi-Aventis
U.S., LLC

8

6495721

Teva Pharm.
Indus., Ltd.

Teva Pharm. Indus. Ltd. v.
Torrent Pharm. Ltd.

Teva Pharm.
Indus. Ltd.

8

6500987

Teva Pharm.
Indus. Ltd.

Teva Pharm. Indus. Ltd. v.
Torrent Pharm. Ltd.

Teva Pharm.
Indus. Ltd.

8

6600073

Teva Pharm.
Indus. Ltd.

Teva Pharm. Indus. Ltd. v.
Torrent Pharm. Ltd.

Teva Pharm.
Indus. Ltd.

8

6897340

Teva Pharm.
Indus. Ltd.

Teva Pharm. Indus. Ltd. v.
Torrent Pharm. Ltd.

Teva Pharm.
Indus. Ltd.

8
9

4777354

Barry Thomas

Thomas v. Adelphia Commc’ns Corp.

Barry Thomas

RE35616

Tillotson Corp.

Tillotson Corp. v. High Five Prods.

Tillotson Corp.

8

6766304

Trading Techs.
Int’l, Inc.

Trading Tech. Int’l v. eSpeed, Inc.

Trading Tech.
Int’l

8

6772132

Trading Techs.
Int’l, Inc.

Trading Tech. Int’l v. eSpeed, Inc.

Trading Tech.
Int’l

8

5091171

Ruey J. Yu & Eugene
J. Van Scott

Tristrata Tech. v. Mary Kay, Inc.

Tristrata Tech.

8

5128984

First Data Res., Inc.

Verizon CA, Inc. v.
Ronald A. Katz Tech.

Verizon CA, Inc.

5

5815551

Ronald A. Katz
Tech. Licensing, LP

Verizon CA, Inc. v.
Ronald A. Katz Tech.

Verizon CA, Inc.

5

6349134

Ronald A. Katz
Tech. Licensing, LP

Verizon CA, Inc. v.
Ronald A. Katz Tech.

Verizon CA, Inc.

5

6054482

Godecke
Aktiengesellschaft

Warner-Lambert Co. v.
Purepac Pharm.

Warner-Lambert
Co.

8

